OxTalks is Changing
OxTalks will soon be transitioning to Oxford Events (full details are available on the Staff Gateway). A two-week publishing freeze is expected to start before the end of Hilary Term to allow all future events to be migrated to the new platform. During this period, you will not be able to submit or edit events on OxTalks. The exact freeze dates will be confirmed on the Staff Gateway and via email to identified OxTalks users.
If you have any questions, please contact halo@digital.ox.ac.uk
Name: Dr Donald Drakeman
Distinguished Research Professor, University of Notre Dame (US), and Fellow, Operations and Technology Management, Cambridge Judge Business School
Events this person is speaking at:
Monday 26 October 2020
Why Were the Checkpoint Inhibitors Developed into Drugs?
Date: 26 October 2020, 12:00 - 13:00
Speaker
:
Dr Donald Drakeman (Distinguished Research Professor, University of Notre Dame (US), and Fellow, Operations and Technology Management, Cambridge Judge Business School)
Venue: Kennedy Institute of Rheumatology, Headington OX3 7FY
Venue Details: This seminar will be held using Zoom. Please register here: https://zoom.us/meeting/register/tJIkdO-rqzwsGtyGKaCW65anWJqcYkaCXzRC
Organisers:
Jennifer Pope (Kennedy Institute of Rheumatology),
Professor Irina Udalova (Kennedy Institute of Rheumatology)
Host:
Professor Fiona Powrie (Kennedy Institute of Rheumatlogy)
